RxDoctor Payments Data

Lindsay Schweikarth

Surgical · Albany, NYNPI 1396042081

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $304,760 of the $324,231 with a category attached, or 94.0%. AbbVie accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$324,231in general payments, 2019–2025

Across 328 payments — averaging $988.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$324K
  • Revance Therapeutics, Inc.$413
  • Galderma Laboratories, L.p.$25

What the payments were for

  • Speaking & faculty fees$304,76094%
  • Travel & lodging$15,9415%
  • Food & beverage$3,5311%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)312$323,793
Revance Therapeutics, Inc.14$413
Galderma Laboratories, L.p.2$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$324,231 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.

See all surgical providers in New York

Other surgical in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →